SurvivorNet on MSN
Drug combination offers much-needed alternative for bladder cancer patients who can’t tolerate chemo
The VOLGA trial was the first to combine two immune checkpoint inhibitors with a targeted therapy in the perioperative ...
Patients with NGB who have refractory detrusor overactivity may benefit from minimally invasive treatment. Refractory detrusor overactivity is marked by persistent urgency, frequency, and incontinence ...
Inlexzo is a new treatment for a type of bladder cancer in adults that hasn’t spread to the muscles and doesn’t respond to Bacillus Calmette-Guérin (BCG) therapy. It’s approved for treating non-muscle ...
An overactive bladder can impact a woman’s quality of life, and it’s something that many women experience. The good news is ...
Pelvic floor dysfunction can contribute to chronic urinary tract infections. Relaxing the pelvic floor muscles in physical ...
If you're like most people, you probably don't give much thought to your bladder or bowel function unless something goes wrong. Unfortunately, though, these types of dysfunctions are common among ...
Although bladder cancer ranks as the sixth most common cancer in the United States, with approximately 85,000 new cases diagnosed each year, it continues to receive limited awareness, advocacy, and ...
HOW TO TAKE THE POST-TEST: To obtain CME credit, please click here after reading the article to take the post-test on myCME.com. Neurogenic lower urinary tract dysfunction—or neurogenic bladder (NGB) ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results